Premier Biosoft Buys Redasoft to Expand Life Science Customer Base | GenomeWeb

Premier Biosoft has acquired privately held bioinformatics company Redasoft in an effort to expand its life sciences software business.

Redasoft markets sequence analysis software dubbed Visual Cloning, which includes vector map drawing capabilities and lets users create graphical maps based on sequence data. It also provides tools for restriction site analysis as well as to search for open reading frames.

Palo Alto, Calif.-based Premier, which is also privately held, expects the new acquisition to expand its reach in the life science software market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.